Friday 6 November 2026 Export MDGL’s income statement to Excel — free account

Madrigal Pharmaceuticals, Inc.

Madrigal Pharmaceuticals, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $958.4 million, up 432.1% from fiscal 2024.

Revenue: +50.1%
EPS: +147.3%
Free cash flow: +53.5%
Total debt: +0.45%

Quarter to September 2026, against a year earlier

397.21 2.89 −0.72%

Follow MDGL

Alert me

Market cap: $9.3B
P/E: 0.0×
Fwd P/E: −68.8×
Dividend yield: —
F-score: n/a
Altman Z: 10.48
Beneish M: 0.50
Dividend safety: n/a

Overview Business Profile Earnings & Analysis Segments Valuation Filings

	Sep '26	Jun '26	Mar '26	Dec '25	Older periods
ROE Full definition →	(24.82%)	(53.31%)	(49.35%)	(42.49%)	+8 more TTM periods Free account
ROA Full definition →	(11.12%)	(28.77%)	(27.83%)	(25.05%)
ROIC Full definition →	(1,480.32%)	(787.33%)	(297.52%)	0.00%
Return on Tangible Assets Full definition →	(16.42%)	(38.86%)	(36.32%)	(30.77%)
Average Days of Receivables Full definition →	58.12	54.67	60.38	51.21
Free Cash Flow per Share Full definition →	(5.77)	(7.08)	(9.39)	(8.65)
Free Cash Flow Full definition →	(168.65)	(206.28)	(272.61)	(193.99)
Capital Expenditures Full definition →	(11.64)	(8.57)	(4.51)	(4.44)
Other line items
Cash ROIC Full definition →	(8.74%)	(12.11%)	(16.02%)	(10.05%)
Accounts Receivable Turnover Full definition →	8.38	9.46	9.10	10.18
Accounts Payable Turnover Full definition →	2.43	3.02	1.53	1.21
Inventory Turnover Full definition →	1.35	1.34	0.94	1.03
Average Days of Payables Full definition →	173.48	115.13	282.77	317.74
Days of Inventory on Hand Full definition →	346.55	331.53	521.21	486.52
Tax Rate Full definition →	0.00	0.00	0.00	0.00
Research and Development Expense of Revenue Full definition →	27.16%	38.17%	40.00%	40.54%
Selling, General and Administrative Expense of Revenue Full definition →	74.48%	78.43%	80.75%	84.91%
Share Based Compensation of Revenue Full definition →	9.39%	9.46%	9.82%	10.24%
Interest Coverage Full definition →	(4.75)	(10.24)	(11.68)	(13.45)
Operating CF/Net income Full definition →	1.01	0.61	0.87	0.66
Depreciation/Fixed assets Full definition →	0.49	0.64	0.83	4.22
Capex/Depreciation Full definition →	(1.69)	(1.16)	(0.67)	(0.70)
Revenue per Share Full definition →	48.82	44.05	39.01	42.72
Operating CF per Share Full definition →	(5.37)	(6.78)	(9.23)	(8.45)
Capex per Share Full definition →	(0.40)	(0.29)	(0.16)	(0.20)
Capex to Sales Full definition →	0.01	0.01	0.00	0.00

Show all line items

Columns are period end dates · fundamentals updated 5 Nov 2026

Stockrow Weekly